BamSEC and AlphaSense Join Forces
Learn More

Rein Therapeutics Inc. – Underwriting Agreements

NASDAQ: RNTX    
Share price (6/2/26): $1.03    
Market cap (6/2/26): $88.1 million
Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1
from SCHEDULE 13G Underwriting agreement
12/34/56
EX-1.1
from 8-K 56 pages Underwriting Agreement Between Rein Therapeutics, Inc. and Konik Capital Partners, LLC, a Division of T.R. Winston and Company as Representative of the Several Underwriters Rein Therapeutics, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1 56 pages Underwriting Agreement Between Rein Therapeutics, Inc. and Konik Capital Partners, LLC, a Division of T.R. Winston and Company as Representative of the Several Underwriters Rein Therapeutics, Inc. Underwriting Agreement
12/34/56
EX-1.2
from S-3 45 pages At the Market Offering Agreement
12/34/56
EX-1.1
from 8-K 39 pages Aileron Therapeutics, Inc. $50,000,000 Common Stock Equity Distribution Agreement Dated: July 26, 2024
12/34/56
EX-1.1
from 8-K 63 pages 4,273,505 Shares of Common Stock Warrants to Purchase 4,273,505 Shares of Common Stock Aileron Therapeutics, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 41 pages Aileron Therapeutics, Inc. Common Stock ($0.001 Par Value Per Share) Capital on Demand™ Sales Agreement
12/34/56
EX-1.1
from 8-K 33 pages Aileron Therapeutics, Inc. Common Stock, Par Value $0.001 Per Share Underwriting Agreement
12/34/56
EX-1.2
from S-3/A 43 pages Aileron Therapeutics, Inc. Common Stock ($0.001 Par Value Per Share) Capital on Demand™ Sales Agreement
12/34/56
EX-1.1
from SC 13D 5 pages March 24, 2017 Merrill Lynch, Pierce, Fenner & Smith Incorporated Jefferies LLC as Representatives of the Several Underwriters to Be Named in the Within-Mentioned Underwriting Agreement C/O Merrill Lynch, Pierce, Fenner & Smith Incorporated One Bryant Park New York, New York 10036 and Jefferies LLC 520 Madison Avenue New York, New York 10022 Re: Proposed Public Offering by Aileron Therapeutics, Inc. Dear Sirs
12/34/56
EX-1.1
from S-1/A 37 pages Aileron Therapeutics, Inc. (A Delaware Corporation) [●] Shares of Common Stock Underwriting Agreement
12/34/56